Clinical Trial Update: A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males [NA]

View source ↗

Summary

This document reports the completion of a randomized, double-blind clinical trial evaluating the safety and efficacy of the X5 HairLaser for treating androgenet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• X5 HairLaser

Snippet

Sponsor: Spencer Forrest, Inc. | Conditions: Androgenetic Alopecia | NA | Status: COMPLETED